ReviewOncoTargets and therapy2018

Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients.

Lei-Yun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.